Neural stem cells (NSCs) and neural progenitor cells (NPCs) are self-renewing and multipotent cells, however, NPCs are considered to be more lineage-restricted with a reduced self-renewing capacity. We present data comparing the expression of 21 markers encompassing pluripotency, self-renewal (NSC) as well as neuronal and glial (astrocyte and oligodendrocyte) lineage specification and 28 extracellular proteoglycan (PG) genes and their regulatory enzymes between embryonic stem cell (ESC)-derived human NSCs (hNSC H9 cells, Thermo Fisher) and human cortex-derived normal human NPCs (nhNPCs, Lonza). The data demonstrates expression differences of multiple lineage and proteoglycan-associated genes between hNSC H9 cells and nhNPCs. Data interpretation of markers and proteoglycans defining NSC and neural cell lineage characterisation can be found in "Cell surface heparan sulfate proteoglycans as novel markers of human neural stem cell fate determination" (Oikari et al. 2015) [1].
Neural stem cells (NSCs) and neural progenitor cells (NPCs) are self-renewing and multipotent cells, however, NPCs are considered to be more lineage-restricted with a reduced self-renewing capacity. We present data comparing the expression of 21 markers encompassing pluripotency, self-renewal (NSC) as well as neuronal and glial (astrocyte and oligodendrocyte) lineage specification and 28 extracellular proteoglycan (PG) genes and their regulatory enzymes between embryonic stem cell (ESC)-derived humanNSCs (hNSCH9 cells, Thermo Fisher) and human cortex-derived normal human NPCs (nhNPCs, Lonza). The data demonstrates expression differences of multiple lineage and proteoglycan-associated genes between hNSCH9 cells and nhNPCs. Data interpretation of markers and proteoglycans defining NSC and neural cell lineage characterisation can be found in "Cell surface heparan sulfate proteoglycans as novel markers of human neural stem cell fate determination" (Oikari et al. 2015) [1].
Specifications
TableThe data provides an extensive panel of markers for better characterisation of humanNSCs and NPCs.The data demonstrates significant and specific differences in expression of pluripotency, NSC self-renewal and neural cell lineage markers between hNSCs and hNPCs.The marker profile data could be used to identify and differentiate between the two cell types to improve their efficacy in research or therapeutic applications.The data provides information on the proteoglycan profile of humanNSCs and NPCs providing potential new additional markers defining lineage progression of NSCs to NPCs.
Data
We compared the expression of 49 selected genes between humanNSCs (hESC-derived hNSCH9 cells, Thermo Fisher) and normal human progenitor cells (nhNPCs, Lonza) following short-term culture under basal growth conditions. Q-PCR data was obtained for pluripotency genes, NSC, neuronal, astrocyte and oligodendrocyte lineage defining genes (n=21; Table 1.) (Fig. 1) with several of these markers also detected through immunofluorescence (IF) (Fig. 2) using specific antibodies (Table 3). In addition, Q-PCR data was obtained for 28 heparan and chondroitin sulphate proteoglycan biosynthesis enzymes and core protein genes (Table 2) ubiquitous to the neural niche [1], [2], [3], [4], [5], [6], [7] in hNSCH9 cells and nhNPCs (Fig. 3, Fig. 4). The data presented provides information on self-renewal and multilineage potential as well as proteoglycan expression differences between the two neural stem/progenitor cell types.
Table 1
Primer sequences of NSC and neural lineage related genes.
Gene
Symbol
Forward primer
Reverse primer
RefSeq
Ref
CD44
CD44
AGCAACTGAGACAGCAACCA
AGACGTACCAGCCATTTGTGT
NM_000610.3
Doublecortin
Dcx
TATGCGCCGAAGCAAGTCTC
TACAGGTCCTTGTGCTTCCG
NM_178152.2
Enolase 2
ENO2
TGCACAGGCCAGATCAAGAC
ACAGCACACTGGGATTACGG
NM_001975.2
Forkhead box A2
FOXA2
CTGGTCGTTTGTTGTGGCTG
GGAGGAGTAGCCCTCGG
NM_021784.4
Galactosylceramidase
GalC
GCCAAGCGTTACCATGATTT
TTTCACTCGCTGGAGACCTT
NM_001201402.1
[8]
Glial fibrillary acidic protein
GFAP
GAGGTTGAGAGGGACAATCTGG
GTGGCTTCATCTGCTTCCTGTC
NM_002055.4
Human telomerase
hTERT
GACGTGGAAGATGAGCGTG
GACGACGTACACACTCATC
NM_001193376.1 NM_198253.2
[9]
Microtubule associated protein 2
MAP2
GACTGCAGCTCTGCCTTTAG
AAGTAAATCTTCCTCCACTGTGAC
NM_002374.3
Mushahi I
MSI I
TGACCAAGAGATCCAGGGGT
CGATTGCGCCAGCACTTTAT
NM_002442.3
Nanog homeobox
NANOG
ACCTCAGCTACAAACAGGTGAA
AAAGGCTGGGGTAGGTAGGT
NM_024865.2
Nestin
NES
CTCAGCTTTCAGGACCCCAA
GTCTCAAGGGTAGCAGGCAA
NM_006617.1
Neurofilament M
NEFM
TGCAGTCCAAGAGCATCGAG
GGATGGTGTCCTGGTAGCTG
NM_005382.2
Neurogenin 2
NEUROG2
AGAGCCAACTAAGATGTTCGTCA
CGATCCGAGCAGCACTAACA
NM_024019.3
Oligodendrocyte transcription factor 1
OLIG1
GTCATCCTGCCCTACTCAGC
CTGCCCAGCAGTAGGATGTAG
NM_138983.2
[8]
Oligodendrocyte transcription factor 2
OLIG2
GACAAGCTAGGAGGCAGTGG
CGGCTCTGTCATTTGCTTCT
NM_005806.3
[8]
POU Class 5 homeobox 1 (OCT3/4)
OCT3/4
ATCTTCAGGAGATATGCAAAGCAGA
TGATCTGCTGCAGTGTGGGT
NM_002701.4
SRY box 1
SOX1
CAACCAGGACCGGGTCAAAC
CCTCGGACATGACCTTCCAC
NM_005986.2
SRY box 2
SOX2
CCACCTACAGCATGTCCTACTCG
GGGAGGAAGAGGTAACCACAGG
NM_003106.3
[10]
S100 Calcium binding protein B
S100B
TTCTGGAAGGGAGGGAGACA
CTCCTGCTCTTTGATTTCCTCT
NM_006272.2
Vimentin
VIM
GGACCAGCTAACCAACGACAAA
CGCATTGTCAACATCCTGTCTG
NM_003380.3
βIII tubulin
TUBB3
GGCCAAGTTCTGGGAAGTCAT
CTCGAGGCACGTACTTGTGA
NM_06086.3
Fig. 1
Q-PCR analysis of pluripotency, NSC self-renewal, neuronal and glial lineage marker genes in hNSC H9 cells and nhNPCs. Relative expression in hNSC H9 cells and nhNPCs of: (A) pluripotency markers; (B) NSC self-renewal markers; (C) neuronal lineage defining markers; and (D) glial lineage defining markers. Relative expression normalised to 18 S, error bars=SD, statistical significance: ⁎p<0.05, ⁎⁎p<0.01, ⁎⁎⁎p<0.001.
Fig. 2
Phenotypic and IF examination of NSC and neural lineage markers in hNSC H9 cells and nhNPCs. Phase-contrast images (20× magnification with 10× magnification inset, scale bar 130 μM) of: (A) hNSC H9 cells at P3 and (B) nhNPCs attached to surface (CC2 chamber slide) during expansion. Immunofluorescence (20× magnification, scale bar 130 μM) in hNSC H9 P3 cells and nhNPCs of stemness and lineage markers: (C) NSC self-renewal markers Nestin (FITC/green) and SOX2 (Cy3/yellow); and (D) neuronal marker MAP2 (FITC/green), astrocyte marker GFAP (Cy3/yellow) and oligodendrocyte marker O1 (AF594/red).
Table 3
Antibodies used for immunofluorescence.
Primary antibodies
Dilution
Company (Cat#)
Anti-Nestin (Mouse IgG)
1:200
Abcam (ab22035)
Anti-SOX2 (Rabbit IgG)
1:1000
Millipore (2003600)
Anti-MAP2 (Mouse IgG)
1:200
Abcam (ab36447)
Anti-GFAP (Rabbit IgG)
1:250
Abcam (ab7260)
Anti-O1 (Mouse IgM)
1:500
Abcam (ab34164)
Isotype Controls
Dilution
Company (Cat#)
Mouse IgG
1:250
Millipore (PP54-100UG)
Rabbit IgG
1:250
Millipore (PP64-100UG)
Mouse IgM
1:500
Millipore (2003599)
Secondary antibodies
Dilution
Company (Cat#)
Donkey Anti-Mouse IgG (FITC, green)
1:250
Millipore (AP192F)
Donkey Anti-Rabbit (H+L) (Cy3, yellow)
1:250
Millipore (AP182C)
Donkey Anti-Mouse IgM (AlexaFluor 594, red)
1:500
Jackson Immunoresearch (#715-585-020)
Table 2
Primer sequences of proteoglycan associated genes.
Gene
Symbol
Forward primer
Reverse primer
RefSeq
Ref
Aggrecan
AGG
TGCATTCCACGAAGCTAACCTT
CGCCTCGCCTTCTTGAAATGT
NM_001135
C5-Epimerase
C5-EP
AGCTGTCAAGCCAACCAAAATAA
CTTACTAGCCAATCACTAGCAGCAA
AY635582
carbohydrate (chondroitin 6) sulfotransferase 3
CHST3
GGTTTTTGTGGTGATAGTTTTTGTCTT
GCTGGGTCGGTGCTGTTG
NM_004273
carbohydrate (chondroitin 4) sulfotransferase 11
CHST11
CTGCTGGAAGTGATGAGGATGA
GATGTCCACACCAAAGGGATTC
NM_018413
Decorin
DCN
TCCTGATGACCGCGACTT
GAGTTGTGTCAGGGGGAAGA
NM_001920.3
Exostose 1
EXT1
TGACAGAGACAACACCGAGTATGA
GCAAAGCCTCCAGGAATCTGAAG
NM_000127.2
Exostose 2
EXT2
CAGTCAATTAAAGCCATTGCCCTG
GGGATCAGCGGGAGGAAGAG
NM_000401
Glypican 1
GPC1
GGACATCACCAAGCCGGACAT
GTCCACGTCGTTGCCGTTGT
NM_002081
Glypican 2
GPC2
TGATCAGCCCCAACAGAGAAA
CCACTTCCAACTTCCTTCAAACC
NM_152742
Glypican 3
GPC3
GATACAGCCAAAAGGCAGCAA
GCCCTTCATTTTCAGCTCATG
NM_004484.
Glypican 4
GPC4
GGTGAACTCCCAGTACCACTTTACA
GCTTCAGCTGCTCCGTATACTTG
NM_001448
Glypican 5
GPC5
GCTCACCTCAATGGACAAAAATT
GTTGGCAAGCGTCTCTTCACT
NM_004466
Glypican 6
GPC6
CAGCCTGTGTTAAGCTGAGGTTT
GATGTGTGTGCGTGGAGGTATGT
NM_005708.
Heparanase
HPSE
TCACCATTGACGCCAACCT
CTTTGCAGAACCCAGGAGGAT
NM_006665.5
Heparan sulphate 2-O sulfotransferase 1
HS2ST1
TCCCGCTCGAAGCTAGAAAG
CGAGGGCCATCCATTGTATG
NM_012262
Heparan sulphate 6-O sulfotransferase 1
HS6ST1
AGCGGACGTTCAACCTCAAGT
GCGTAGTCGTACAGCTGCATGT
NM_004807
Heparan sulphate 6-O sulfotransferase 2
HS6ST2
TCTGGAAAGTGCCAAGTCAAATC
ATGGCGAAATAAAGTTCATGTTGAA
NM_147175
Heparan sulphate 6-O sulfotransferase 3
HS6ST3
ACATCACGCGGGCTTCTAACGT
GGCGGTCCCTCTGGTGCTCTA
NM_153456
N-deacetylase/N-sulfotransferase 1
NDST1
TGGTCTTGGATGGCAAACTG
CGCCAAGGTTTTGTGGTAGTC
NM_001543
N-deacetylase/N-sulfotransferase 2
NDST2
CCTATTTGAAAAAAGTGCCACCTACT
GCAGGGTTGGTGAGCACTGT
NM_003635
N-deacetylase/N-sulfotransferase 3
NDST3
ACCCTTCAGACCGAGCATACTC
CCCGGGACCAAACATCTCTT
NM_004784
N-deacetylase/N-sulfotransferase 4
NDST4
ATAAAGCCAATGAGAACAGCTTACC
GGTAATATGCAGCAAAGGAGATTGA
NM_022569
Perlecan
PER
TGGACACATTCGTACCTTTCTGA
CCTCGGACACCTCTCGAAACT
NM_005529
Syndecan 1
SDC1
CTGGGCTGGAATCAGGAATATTT
CCCATTGGATTAAGTAGAGTTTTGC
BC008765.2
Syndecan 2
SDC2
AGCTGACAACATCTCGACCACTT
GCGTCGTGGTTTCCACTTTT
NM_002998.3
Syndecan 3
SDC3
CTTGGTCACACTGCTCATCTATCG
GCATAGAACTCCTCCTGCTTGTC
AF248634
Syndecan 4
SDC4
CCACGTTTCTAGAGGCGTCACT
CTGTCCAACAGATGGACATGCT
BC030805.1
Versican
VCN
TGGAATGATGTTCCCTGCAA
AAGGTCTTGGCATTTTCTACAACAG
NM_004385.4
Fig. 3
Q-PCR analysis of proteoglycan biosynthesis enzyme gene expression in hNSC H9 cells and nhNPCs. Relative expression in hNSC H9 cells and nhNPCs of: (A) HS chain synthesising and modifying enzymes; (B) HS chain N-deacelylating/N-sulfating enzymes; (C) HS chain sulfating enzymes; and (D) CS chain sulfating enzymes. Relative expression normalised to 18 S, error bars=SD, statistical significance: ⁎p<0.05, ⁎⁎p<0.01, ⁎⁎⁎p<0.001.
Fig. 4
Q-PCR analysis of proteoglycan core protein gene expression in hNSC H9 cells and nhNPCs. Relative expression in hNSC H9 cells and nhNPCs of: cell surface HSPGs (A) syndecans; (B) glypicans; and extracellular CSPGs and HSPGs (C) aggrecan, versican, perlecan and decorin. Relative expression normalised to 18 S, error bars=SD, statistical significance: ⁎p<0.05, ⁎⁎p<0.01, ⁎⁎⁎p<0.001.
Experimental design, materials and methods
Cell culture
Gibco® human neural stem cells derived from NIH-approved H9 (WA09) embryonic stem cells (hNSCH9 cells) were cultured as a monolayer on Geltrex® coated culture dishes in StemPro® NSC serum-free medium (NSC SFM) containing KnockOUT™ DMEM/F-12 supplemented with 2% StemPro® Neural Supplement, 20 ng/ml FGFb and EGF and 2 mM GlutaMAX™ (cells and culture reagents obtained from Thermo Fisher). hNSCH9 cells were cultured in p35 (10 cm2) dishes with culture medium changed every two days and cells passaged at 90% confluence using TrypLE. hNSCH9 cells were passaged twice and harvested for RNA at passage 3 (P3). Normal Human Neural Progenitor Cells (nhNPCs) isolated from the human brain cortex were cultured as neurospheres in Neural Progenitor Maintenance Bulletkit™ medium (NPMM) containing 200 mL of Neural Progenitor Basal Medium supplemented with 0.4 mL rhFGF-B, 0.4 mL rhEGF, 4 mL Neural Survival Factor-1 and 0.4 mL Gentamicin/Amphotericin (cells and culture reagents obtained from Lonza). nhNPC neurosphere cultures were established by defrosting the cell ampule according to the manufacturer’s instructions and dividing the cells into two T75 (75 cm2) flasks containing 20 mL of NPMM. hNSCH9 and nhNPCs cultures were maintained in 5% CO2 at 37 °C in a humidified atmosphere with phenotype of the cells monitored under an Olympus IX81 inverted phase-contrast microscope.
RNA extraction
RNA was harvested from cultured cells using TRIzol® reagent (Invitrogen) using the Direct-zol™ RNA miniprep kit (Zymo Research) according to the manufacturer’s instructions with samples treated in-column with DNase I (Zymo Research). RNA was eluted in RNase-free H2O and concentration and quality of RNA determined with a NanoDrop spectrophotometer (Thermo Scientific).
cDNA synthesis
For conversion of RNA into cDNA, 150 ng of RNA was incubated with 200 ng of Random Primer (New England BioLabs) at 65 °C for 10 min in a reaction made up to 20 μl with Milli-Q-H2O. Samples were then incubated with 10 U of Transcriptor Reverse Transcriptase (Roche) and 1 mM dNTPs (New England Biolabs), 20 U of RNaseOUT (Invitrogen) in 1x RT reaction buffer in a total reaction volume of 30 μl. For the reverse transcription reaction samples were incubated at 25 °C for 10 min, then at 55 °C for 30 min and finally at 85 °C for 5 min. Concentration and quality of cDNA was measured on a NanoDrop spectrophotometer and cDNA was diluted to 40 ng/mL working concentrations.
Quantitative real-time PCR
Relative gene expression was detected using quantitative real-time PCR (Q-PCR). The 10 μl reaction volume contained 5 μl of SYBR®-Green PCR Master Mix (Promega), 200 ng of forward and reverse primer, 0.1 μl CXR reference dye (Promega) and 120 ng cDNA template. Amplification was monitored on an Applied Biosystems 7900HT Fast Real-Time PCR system with an enzyme activation of 2 min at 50 °C and 3 min at 95 °C followed by 50 cycles of 3 s at 95 °C and 30 s at 60 °C. The cycle threshold (Ct) values were normalised against the endogenous control 18 S (forward primer TTCGAGGCCCTGTAATTGGA, reverse primer GCA GCAACTTAATATACGCTAT) Ct values (ΔCt value) included in each run, and relative gene expression was determined by the ΔΔCt value (2(−Δ). For ease of graphic presentation of relative gene expression, ΔΔCt values were multiplied by 106. Primer sequences for detected NSC and neural lineage genes are presented in Table 1 and primer sequences for heparan and chondroitin sulphate proteoglycan associated genes are presented in Table 2.
Immunofluorescence (IF)
Expression of selected NSC and neural lineage marker proteins were detected via IF using an Olympus IX81 inverted phase-contrast fluorescent microscope and images acquired using Volocity software (Perkin-Elmer) on a Hamamatsu Orca camera. For imaging, cells were plated on 8-well CC2-coated chamber slides (Lab-Tek) at 20–30×104 cells/well and cells were cultured for 3–4 days before fixing and staining. Briefly, culture medium was removed, cells rinsed with 1× PBS with Ca2+ and Mg2+ and fixed with 4% paraformaldehyde. After this cells were blocked (5% Donkey serum, 1% BSA in PBS with or without 0.1% Triton-X to allow permeabilisation) and primary antibodies were incubated overnight at 4 °C. Isotype control antibodies were used as a negative control. After 24 h incubation, primary antibodies were removed, cells rinsed with 1× PBS with Ca2+ and Mg2+ and cells incubated with secondary antibodies for 2 h at room temperature. Finally, cells were rinsed with 1× PBS with Ca2+ and Mg2+ and slides mounted with DAPI (ab104139, Abcam). Antibodies and dilutions used are presented in Table 3.
Statistical analysis
For Q-PCR analysis each gene was detected in quadruplicate per sample. Paired t-test was used to determine statistical significance and defined as * p<0.5, ** p<0.01 and *** p<0.001. Error bars represent SD.
Subject area
Cell biology
More specific subject area
Human neural stem cell (hNSC) and human neural progenitor cell (hNPC) marker characterisation
Type of data
Text file, graphs and immunofluorescence images
How data was acquired
in vitro culture/expansion and phase-contrast fluorescence microscopy data for phenotypic analysis was obtained on an Olympus IX81 inverted fluorescent microscope via Volocity Imaging package; raw Q-PCR data was obtained on Applied Biosystems 7900HT Fast Real-Time PCR system
Data format
Analysed
Experimental factors
hNSC H9 and nhNP cells were cultured under basal medium conditions
Experimental features
hNSC H9 cells (Thermo Fisher) were cultured as a monolayer and nhNP cells (Lonza) were cultured as neurospheres in standard maintenance medium provided by the manufacturer. RNA was harvested and transcribed to cDNA and gene expression of a panel of 49 genes examined by Q-PCR. Specific neural cell lineage markers were further detected through immunofluorescence (IF)
Data source location
Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland Australia
Authors: Lotta E Oikari; Rachel K Okolicsanyi; Aro Qin; Chieh Yu; Lyn R Griffiths; Larisa M Haupt Journal: Stem Cell Res Date: 2015-12-17 Impact factor: 2.020
Authors: Cristal I Gama; Sarah E Tully; Naoki Sotogaku; Peter M Clark; Manish Rawat; Nagarajan Vaidehi; William A Goddard; Akinori Nishi; Linda C Hsieh-Wilson Journal: Nat Chem Biol Date: 2006-07-30 Impact factor: 15.040
Authors: Rebekah M Samsonraj; Michael Raghunath; James H Hui; Ling Ling; Victor Nurcombe; Simon M Cool Journal: Gene Date: 2013-02-01 Impact factor: 3.688
Authors: Fredrik Lanner; Kian Leong Lee; Marcus Sohl; Katarina Holmborn; Henry Yang; Johannes Wilbertz; Lorenz Poellinger; Janet Rossant; Filip Farnebo Journal: Stem Cells Date: 2010-02 Impact factor: 6.277
Authors: Juliana L Dreyfuss; Caio V Regatieri; Thais R Jarrouge; Renan P Cavalheiro; Lucia O Sampaio; Helena B Nader Journal: An Acad Bras Cienc Date: 2009-09 Impact factor: 1.753
Authors: Rachel K Okolicsanyi; Lotta E Oikari; Chieh Yu; Lyn R Griffiths; Larisa M Haupt Journal: Front Mol Neurosci Date: 2018-04-24 Impact factor: 5.639
Authors: Shang Song; Danielle Amores; Cheng Chen; Kelly McConnell; Byeongtaek Oh; Ada Poon; Paul M George Journal: Sci Rep Date: 2019-12-20 Impact factor: 4.379